7 completed. 7 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Phase 1 | 1 | Completed 1 |
Follow Inflammatory Response: new trials by email Literature Review of Inflammatory Response trials Research Report on Inflammatory Response
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction Methylprednisolone, Isotonic saline - ST Elevation Myocardial Infarction, Inflammatory Response | Phase 2 | Completed | Thomas Engstrom | 530 | 2022-11-14 | 2026-03-27 |
| An Inflammatory Challenge Using Endotoxin Placebo, Endotoxin - Alcohol Use Disorder, Inflammatory Response | Phase 2 | Completed | University of California, Los Angeles | 20 | 2021-10-19 | 2025-05-01 |
| Asses the Anti-inflammatory Effects of Short Term Copaxone Therapy on Patients the Acute Decompensated Heart Failure Copaxone, guideline directed medical therapy (GDMT) - Acute Decompensated Heart Failure, Cytokine Storm | Phase 2 | Completed | Hadassah Medical Organization | 14 | 2021-01-04 | 2023-08-22 |
| An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 Icosapent ethyl - COVID-19, Inflammatory Response | Phase 2 | Completed | Canadian Medical and Surgical Knowledge Translation Research Group | 100 | 2020-06-04 | 2021-12-22 |
| Effects of Metformin in a Non-Diabetic Patient Population MetFORMIN Hydrochloride ER, Placebo - Inflammatory Response | Phase 1 / Phase 2 | Completed | Brian Zuckerbraun | 32 | 2019-01-22 | 2023-01-11 |
| Tramadol Versus Lidocaine Infiltration for Tonsillectomy peritonsillar infiltration - Peri-tonsillar Analgesic Infiltration, Tonsillectomy | Phase 2 | Completed | Imam Abdulrahman Bin Faisal University | 90 | 2011-12-01 | 2014-03-18 |
| Immune Effects of Vitamin D in Hemodialysis Patients paricalcitol - End Stage Renal Disease, Hemodialysis | Phase 2 | Completed | Renal Research Institute | 20 | 2004-12-01 | 2009-05-13 |
Alcoholism (1) · COVID-19 (1) · Cardiovascular Diseases (1) · Consciousness Disorders (1) · Cytokine Release Syndrome (1) · Fractures, Stress (1) · Heart Failure (1) · Inflammation (1) · Kidney Failure, Chronic (1) · Myocardial Reperfusion Injury (1) · Pain, Postoperative (1) · Reperfusion Injury (1) · ST Elevation Myocardial Infarction (1) · Thrombosis (1)
Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (4) · Cardiovascular Diseases (3) · Heart Diseases (2) · Neurologic Manifestations (2) · Postoperative Complications (2) · Signs and Symptoms (2) · Vascular Diseases (2) · Alcohol-Related Disorders (1) · Cardiomyopathies (1) · Chemically-Induced Disorders (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1)
Sodium Chloride (2) · Endotoxins (1) · Glatiramer Acetate (1) · Metformin (1) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · eicosapentaenoic acid ethyl ester (1) · paricalcitol (1)
Brian Zuckerbraun (1) · Canadian Medical and Surgical Knowledge Translation Research Group (1) · Hadassah Medical Organization (1) · Imam Abdulrahman Bin Faisal University (1) · Renal Research Institute (1) · Thomas Engstrom (1) · University of California, Los Angeles (1)
United States (3) · Canada (1) · Denmark (1) · Israel (1) · Saudi Arabia (1)
Abdulhadi Al'Saflan, MD (1) · Alaa M. Khidr, MD (1) · Brian Zuckerbraun, MD (1) · Hany A. Mowafi, MD (1) · Jasmine M Madsen, MD (1) · Lara Ray, PhD (1) · Nathan W Levin, MD (1) · Offer Amir, PhD (1) · Subodh Verma, MD, PhD (1)